1. Home
  2. NPFD vs SRDX Comparison

NPFD vs SRDX Comparison

Compare NPFD & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPFD
  • SRDX
  • Stock Information
  • Founded
  • NPFD 2021
  • SRDX 1979
  • Country
  • NPFD United States
  • SRDX United States
  • Employees
  • NPFD N/A
  • SRDX N/A
  • Industry
  • NPFD Trusts Except Educational Religious and Charitable
  • SRDX Medical/Dental Instruments
  • Sector
  • NPFD Finance
  • SRDX Health Care
  • Exchange
  • NPFD Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • NPFD 480.1M
  • SRDX 402.2M
  • IPO Year
  • NPFD N/A
  • SRDX 1998
  • Fundamental
  • Price
  • NPFD $19.72
  • SRDX $27.29
  • Analyst Decision
  • NPFD
  • SRDX Buy
  • Analyst Count
  • NPFD 0
  • SRDX 3
  • Target Price
  • NPFD N/A
  • SRDX $43.00
  • AVG Volume (30 Days)
  • NPFD 64.7K
  • SRDX 96.9K
  • Earning Date
  • NPFD 01-01-0001
  • SRDX 11-05-2025
  • Dividend Yield
  • NPFD 6.28%
  • SRDX N/A
  • EPS Growth
  • NPFD N/A
  • SRDX N/A
  • EPS
  • NPFD N/A
  • SRDX N/A
  • Revenue
  • NPFD N/A
  • SRDX $120,801,000.00
  • Revenue This Year
  • NPFD N/A
  • SRDX N/A
  • Revenue Next Year
  • NPFD N/A
  • SRDX $3.38
  • P/E Ratio
  • NPFD N/A
  • SRDX N/A
  • Revenue Growth
  • NPFD N/A
  • SRDX N/A
  • 52 Week Low
  • NPFD $14.50
  • SRDX $26.00
  • 52 Week High
  • NPFD $18.07
  • SRDX $40.39
  • Technical
  • Relative Strength Index (RSI)
  • NPFD 44.10
  • SRDX 26.65
  • Support Level
  • NPFD $19.73
  • SRDX $26.78
  • Resistance Level
  • NPFD $20.00
  • SRDX $28.69
  • Average True Range (ATR)
  • NPFD 0.22
  • SRDX 0.67
  • MACD
  • NPFD -0.04
  • SRDX 0.07
  • Stochastic Oscillator
  • NPFD 11.23
  • SRDX 23.15

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The fund invests a majority of its assets in variable-rate preferred securities and other variable-rate income-producing securities. The rest of its investments can be made in contingent capital securities or contingent convertible securities, convertible securities, corporate debt securities, U.S. government securities, residential and commercial mortgage-backed securities, fixed-rate preferred securities, senior loans and loan participations and assignments, sovereign debt instruments, debt securities issued by supranational agencies, and/or taxable and tax-exempt municipal bonds.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: